PFOA targets B cell lipid raft organization and function
PFOA 针对 B 细胞脂筏组织和功能
基本信息
- 批准号:10665277
- 负责人:
- 金额:$ 42.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-12 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAnimalsAntibody FormationAntigensAutomobile DrivingB-Cell ActivationB-LymphocytesBiochemicalBiochemistryBiological AssayBiomimeticsBiophysicsCD80 AntigensCell membraneCell surfaceCellsCholesterolDataEnvironmentExposure toFemaleFoodHumoral ImmunitiesImmune systemImpairmentInterventionLigand BindingLinkLipidsMembraneMembrane MicrodomainsMembrane ProteinsMissionModelingMolecularMolecular TargetMusNMR SpectroscopyOrganic ChemicalsPhospholipidsPlantsPoly-fluoroalkyl substancesPopulationQuantitative MicroscopyReceptor SignalingResearchRoleSignal TransductionSoilSphingolipidsTestingTherapeuticThermodynamicsToxicologyUp-RegulationViscosityWater Supplyamphiphilicityarmcell typecellular targetingchemical stabilityconsumer productcytokinedrinking waterexperimental studyhigh rewardhigh riskimaging approachimmunotoxicityimprovedin vivo evaluationinnovationinsightmalenovelperfluorooctanoic acidpreventreceptorrecruitresponsetransmission process
项目摘要
PROJECT SUMMARY
Per- and polyfluoroalkyl substances (PFAS) are a group of synthetic organic chemicals that are widely used in
consumer products. Given their chemical stability, PFAS are highly persistent in the environment and are
detected in the water supply, food products, soil, and plants/animals. PFAS can exert immunotoxic effects.
Notably, there is evidence that the legacy PFAS known as perfluorooctanoic acid (PFOA) can impair humoral
immunity, the arm of the immune system that drives antibody production from B cells. A major limitation in the
field is that underlying targets and mechanisms by which PFOA dysregulates humoral immunity are unknown.
Therefore, the objective of this application is to explore new cellular and molecular mechanistic targets of
PFOA. One novel target of PFOA is B cell lipid rafts. Lipid rafts are tightly packed regions of the plasma
membrane made of sphingolipids/phospholipids and cholesterol that serve as platforms for membrane proteins
to efficiently transmit downstream signals. Plasma membrane lipid rafts have a critical role in controlling B cell
activation. Thus, understanding how PFOA exposure leads to dysregulated B cell lipid raft formation would
provide a new mechanistic target by which this compound induces immunotoxicity. Herein, we propose the
central hypothesis that PFOA increases the abundance of unstable plasma membrane lipid rafts of
naïve B cells. Mechanistically, this is driven by PFOA incorporating into lipid rafts and thereby driving lipid raft-
associated lipids into non-raft regions of the plasma membrane. As a consequence, PFOA creates an
impediment toward effective localization of signaling receptors within lipid rafts, which is required for efficient
downstream activation of naïve B cells. To test the hypothesis, we propose two aims that innovatively merge
the fields of humoral immunity, toxicology, and membrane biochemistry/biophysics. Aim 1 will investigate how
PFOA dysregulates the stability and abundance of B cell lipid rafts. Aim 2 will determine how PFOA
dysregulates recruitment of specific receptors into lipid rafts and its functional consequences. Overall, this high
risk/high reward study will establish B cell lipid raft biophysical organization as a new molecular target of
PFOA. These studies will have a sustained impact by opening a new avenue of research focused on
understanding how PFOA and other PFAS control lipid raft organization and function of differing B cell
populations and other key cell types of humoral immunity. Ultimately, this line of research will improve our
understanding of how PFAS exert immunotoxic effects, which can lead to targeted interventions and improved
therapeutics in response to exposure.
项目概要
全氟烷基物质和多氟烷基物质 (PFAS) 是一组广泛用于
鉴于其化学稳定性,PFAS 在环境中具有高度持久性,并且
在供水、食品、土壤和植物/动物中检测到的 PFAS 可以产生免疫毒性作用。
值得注意的是,有证据表明,被称为全氟辛酸 (PFOA) 的传统 PFAS 会损害体液
免疫,驱动 B 细胞产生抗体的免疫系统的一个主要限制。
目前,PFOA 调节体液免疫的潜在目标和机制尚不清楚。
因此,本应用的目的是探索新的细胞和分子机制靶点
PFOA 的一个新靶标是 B 细胞筏脂质。脂筏是血浆中紧密堆积的区域。
由鞘脂/磷脂和胆固醇制成的膜,作为膜蛋白的平台
质膜脂筏在控制 B 细胞中发挥着关键作用。
因此,了解 PFOA 暴露如何导致 B 细胞脂筏形成失调。
提供了该化合物诱导免疫毒性的新机制靶标。
中心假设是 PFOA 增加了不稳定质膜脂筏的丰度
从机制上讲,这是由 PFOA 掺入脂筏并驱动脂筏驱动的。
相关脂质区域进入质膜的非筏,因此,PFOA 产生了一个
阻碍脂筏内信号受体有效定位,这是有效脂筏所必需的
为了检验这一假设,我们提出了两个创新性合并的目标。
体液免疫、毒理学和膜生物化学/生物物理学领域将研究如何进行。
PFOA 失调 B 细胞筏脂质的稳定性和丰度 目标 2 将如何确定 PFOA。
总体而言,这种高水平会调节脂筏中特定受体的募集及其功能后果。
风险/高回报研究将建立 B 细胞脂筏生物物理组织作为新的分子靶标
这些研究将开辟一条新的研究途径,产生持续的影响。
了解 PFOA 和其他 PFAS 如何控制不同 B 细胞的脂筏组织和功能
最终,这一系列研究将改善我们的体液免疫。
了解 PFAS 如何发挥免疫毒性作用,这可以导致有针对性的干预措施并改善
对暴露做出反应的治疗方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SAAME R SHAIKH其他文献
SAAME R SHAIKH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SAAME R SHAIKH', 18)}}的其他基金
SPMs, linoleic acid, and antibody levels in obesity
肥胖症中的 SPM、亚油酸和抗体水平
- 批准号:
10189019 - 财政年份:2021
- 资助金额:
$ 42.54万 - 项目类别:
Suppressing inflammation and boosting humoral immunity with n-3 PUFAs
用 n-3 PUFA 抑制炎症并增强体液免疫
- 批准号:
9349651 - 财政年份:2015
- 资助金额:
$ 42.54万 - 项目类别:
Suppressing inflammation and boosting humoral immunity with n-3 PUFAs
用 n-3 PUFA 抑制炎症并增强体液免疫
- 批准号:
9031050 - 财政年份:2015
- 资助金额:
$ 42.54万 - 项目类别:
Suppressing inflammation and boosting humoral immunity with n-3 PUFAs
用 n-3 PUFA 抑制炎症并增强体液免疫
- 批准号:
8880644 - 财政年份:2015
- 资助金额:
$ 42.54万 - 项目类别:
Suppressing inflammation and boosting humoral immunity with n-3 PUFAs
用 n-3 PUFA 抑制炎症并增强体液免疫
- 批准号:
9488876 - 财政年份:2015
- 资助金额:
$ 42.54万 - 项目类别:
相似国自然基金
动物双歧杆菌对不同聚合度低聚木糖同化差异性的分子机制研究
- 批准号:32302789
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
基于扁颅蝠类群系统解析哺乳动物脑容量适应性减小的演化机制
- 批准号:32330014
- 批准年份:2023
- 资助金额:215 万元
- 项目类别:重点项目
以秀丽隐杆线虫为例探究动物在不同时间尺度行为的神经基础
- 批准号:32300829
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
城市化对土壤动物宿主-寄生虫关系的影响机制研究
- 批准号:32301430
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
城市河流底栖动物性状β多样性的空间格局及群落构建研究
- 批准号:32301334
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Determining how Doublesex and sex-specific steroid hormone signaling control gonad development
确定双性和性别特异性类固醇激素信号如何控制性腺发育
- 批准号:
10679359 - 财政年份:2023
- 资助金额:
$ 42.54万 - 项目类别:
Anti-flavivirus B cell response analysis to aid vaccine design
抗黄病毒 B 细胞反应分析有助于疫苗设计
- 批准号:
10636329 - 财政年份:2023
- 资助金额:
$ 42.54万 - 项目类别:
Flu Vaccine Production Using a Novel Pandemic Response and Prevention Manufacturing Method
使用新型流行病应对和预防制造方法生产流感疫苗
- 批准号:
10698431 - 财政年份:2023
- 资助金额:
$ 42.54万 - 项目类别:
Maturation of human humoral immunity through repeat malaria challenges
通过重复疟疾挑战使人体体液免疫成熟
- 批准号:
10720245 - 财政年份:2023
- 资助金额:
$ 42.54万 - 项目类别:
Flu Vaccine Production Using a Novel Pandemic Response and Prevention Manufacturing Method
使用新型流行病应对和预防制造方法生产流感疫苗
- 批准号:
10698431 - 财政年份:2023
- 资助金额:
$ 42.54万 - 项目类别: